Serum sex hormone-binding globulin and testosterone in relation to cardiovascular disease risk factors in young men: a population-based study — Dexter Canoy (2014) | RDL Network
Serum sex hormone-binding globulin and testosterone in relation to cardiovascular disease risk factors in young men: a population-based study
Article 2014 en
Authors
DC
Dexter Canoy
TB
Thomas M. Barber
AP
Anneli Pouta
Abstract
1 min read
Reduced sex hormone-binding globulin (SHBG) concentration predicts insulin resistance and type 2 diabetes, but its association with cardiovascular disease (CVD) risk is unclear. We examined the association between SHBG and cardiovascular risk factors, independently of total testosterone (TT), in young men.
Judith S. Brand, Maroeska M. Rovers, Bu B. Yeap, Harald J. Schneider, Tomi‐Pekka Tuomainen, Robin Haring, Giovanni Corona, Altan Onat, Marcello Maggio, Claude Bouchard, Peter C.Y. Tong, Richard Y. T. Chen, Masahiro Akishita, Jourik A. Gietema, Marie‐Hélène Gannagé‐Yared, Anna‐Lena Undén, Aarno Hautanen, N. P. Goncharov, Philip Kumanov, S. A. Paul Chubb, Osvaldo P. Almeida, Hans‐Ulrich Wïttchen, Jens Klotsche, Henri Wallaschofski, Henry Völzke, Jussi Kauhanen, Jukka T. Salonen, Luigi Ferrucci, Yvonne T. van der Schouw
Qin Wang, Antti J. Kangas, Pasi Soininen, Marjaana Tiainen, Tuulia Tynkkynen, Katri Puukka, A Ruokonen, Jorma Viikari, Mika Kähönen, Terho Lehtimäki, Veikko Salomaa, Markus Perola, George Davey Smith, Olli T. Raitakari, Paul M Ridker, Peter Würtz, Johannes Kettunen, Mika Ala‐Korpela
Discussion(0)
No comments yet. Be the first to comment.